BCL2 and neoplasm: Upon activation of the IL-6/JAK/STAT3 signaling pathway, the expression of genes such as Cyclin D1 and Bcl-2 is upregulated, promoting tumor cell cycle progression and inhibiting apoptosis, thereby enhancing tumor cell proliferation and survival (94).